Skip to content

Enzon Pharmaceuticals Inc Sustainability Reports

The company historically operated as a public platform managing pharmaceutical royalty revenues and licensing marketing rights. Following a 2026 merger, it serves as the public parent organization for a global producer and distributor of cellulosic, fibrous, and plastic food casings.

Sector: Manufacturing

Country: United States

Exchange: OTC Markets

LEI: 529900VN48L8QCMVPV36

7 reports from 2005 to 2013